Zdrowie i gospodarka · 27/12/2022

FDA Classifies Adjunctive Hemodynamic Indicator With Decision Point as Class II Device

The US Food and Drug Administration has classified the adjunctive hemodynamic indicator with decision point as a Class II device, requiring special controls to ensure its safety and effectiveness, with the goal of improving patient access to innovative devices.